ADAR1 Capital Management, LLC Q4 2025 Filing
Filed February 17, 2026
Portfolio Value
$1.4T
Holdings
256
Report Date
Q4 2025
Filing Type
13F-HR
All Holdings (256 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 201 | JBIOJADE BIOSCIENCES INC | 21,000 | $324.0M | 0.02% | |
| 202 | SGRYSURGERY PARTNERS INC | 20,000 | $309.0M | 0.02% | |
| 203 | JDJD.COM INC | 10,000 | $287.0M | 0.02% | |
| 204 | PCAPPROCAP ACQUISITION CORP | 26,940 | $275.0M | 0.02% | |
| 205 | DRUGBRIGHT MINDS BIOSCIENCES INC | 3,500 | $273.0M | 0.02% | |
| 206 | IDXXIDEXX LABS INC | 400 | $270.0M | 0.02% | |
| 207 | SPROSPERO THERAPEUTICS INC | 113,839 | $265.0M | 0.02% | |
| 208 | IMMXIMMIX BIOPHARMA INC | 50,000 | $261.0M | 0.02% | |
| 209 | CATXPERSPECTIVE THERAPEUTICS INC | 95,193 | $261.0M | 0.02% | |
| 210 | JSPRJASPER THERAPEUTICS INC | 140,000 | $256.0M | 0.02% | |
| 211 | SNDXSYNDAX PHARMACEUTICALS INC | 12,000 | $252.0M | 0.02% | |
| 212 | OGNORGANON & CO | 35,000 | $250.0M | 0.02% | |
| 213 | ANNXANNEXON INC | 48,000 | $240.0M | 0.02% | |
| 214 | PEPGPEPGEN INC | 36,842 | $239.0M | 0.02% | |
| 215 | EOLSEVOLUS INC | 35,859 | $238.0M | 0.02% | |
| 216 | SP4PACHIEVE LIFE SCIENCES INC | 47,800 | $237.0M | 0.02% | |
| 217 | RAREULTRAGENYX PHARMACEUTICAL IN | 10,000 | $230.0M | 0.02% | Call |
| 218 | BCAXBICARA THERAPEUTICS INC | 13,705 | $230.0M | 0.02% | |
| 219 | RXSTRXSIGHT INC | 21,803 | $227.0M | 0.02% | |
| 220 | MISTMILESTONE PHARMACEUTICALS IN | 100,100 | $202.0M | 0.01% | |
| 221 | WHWKWHITEHAWK THERAPEUTICS INC | 77,593 | $187.0M | 0.01% | |
| 222 | TRAWTRAWS PHARMA INC | 154,431 | $174.0M | 0.01% | |
| 223 | KALVKALVISTA PHARMACEUTICALS INC | 10,000 | $161.0M | 0.01% | |
| 224 | OTLKOUTLOOK THERAPEUTICS INC | 100,000 | $158.0M | 0.01% | Put |
| 225 | RLMDRELMADA THERAPEUTICS INC | 30,866 | $149.0M | 0.01% | |
| 226 | VYNEVYNE THERAPEUTICS INC | 253,791 | $147.0M | 0.01% | |
| 227 | SLNSILENCE THERAPEUTICS PLC | 23,643 | $143.0M | 0.01% | |
| 228 | RXRXRECURSION PHARMACEUTICALS IN | 35,000 | $143.0M | 0.01% | |
| 229 | VYGRVOYAGER THERAPEUTICS INC | 35,000 | $137.0M | 0.01% | |
| 230 | ZONECLEANCORE SOLUTIONS INC | 521,980 | $135.0M | 0.01% | |
| 231 | CMMBCHEMOMAB THERAPEUTICS LTD | 80,000 | $132.0M | 0.01% | |
| 232 | PMVPPMV PHARMACEUTICALS INC | 101,008 | $126.0M | 0.01% | |
| 233 | GBIOGENERATION BIO CO | 22,144 | $125.0M | 0.01% | |
| 234 | NEUPNEUPHORIA THERAPEUTICS INC | 30,000 | $116.0M | 0.01% | |
| 235 | CLOVCLOVER HEALTH INVESTMENTS CO | 48,300 | $113.0M | 0.01% | |
| 236 | ZNTLZENTALIS PHARMACEUTICALS INC | 80,000 | $108.0M | 0.01% | |
| 237 | BCABBIOATLA INC | 183,107 | $103.0M | 0.01% | |
| 238 | SABSSAB BIOTHERAPEUTICS INC | 26,344 | $98.0M | 0.01% | |
| 239 | STISOLIDION TECHNOLOGY INC | 13,500 | $95.0M | 0.01% | Call |
| 240 | KYNBFIBROGEN INC | 10,469 | $91.0M | 0.01% | |
| 241 | RZLTREZOLUTE INC | 38,679 | $91.0M | 0.01% | |
| 242 | PLRXPLIANT THERAPEUTICS INC | 73,819 | $90.0M | 0.01% | |
| 243 | NMRANEUMORA THERAPEUTICS INC. | 50,600 | $90.0M | 0.01% | |
| 244 | LITSLITE STRATEGY INC | 67,292 | $88.0M | 0.01% | |
| 245 | IRDOPUS GENETICS INC | 40,000 | $80.0M | 0.01% | |
| 246 | KALAKALA BIO INC | 141,480 | $78.0M | 0.01% | |
| 247 | VERUVERU INC | 35,000 | $74.0M | 0.01% | |
| 248 | QTTBQ32 BIO INC | 20,000 | $66.0M | 0.00% | |
| 249 | MREOMEREO BIOPHARMA GROUP PLC | 150,000 | $62.0M | 0.00% | |
| 250 | BMEABIOMEA FUSION INC | 43,420 | $53.0M | 0.00% | |
| 251 | ASPCRA SPAC III ACQUISITION CORP | 215,000 | $40.0M | 0.00% | |
| 252 | ATYRATYR PHARMA INC | 50,685 | $39.0M | 0.00% | |
| 253 | IVFINVO FERTILITY INC. | 26,722 | $20.0M | 0.00% | |
| 254 | PRQRPROQR THRAPEUTICS N V | 10,000 | $20.0M | 0.00% | |
| 255 | IOBTIO BIOTECH INC | 24,964 | $15.0M | 0.00% | |
| 256 | CHRSCOHERUS ONCOLOGY INC | 10,366 | $14.0M | 0.00% |
PreviousPage 3 of 3